Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.715 USD | +0.62% | -7.62% | +0.88% |
May. 09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
May. 08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.88% | 391M | |
+39.59% | 50.93B | |
-0.21% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+12.94% | 26.02B | |
-22.33% | 18.9B | |
+8.70% | 13.21B | |
+24.58% | 12.17B | |
+29.10% | 12.16B |
- Stock Market
- Equities
- CCCC Stock
- News C4 Therapeutics, Inc.
- Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating